Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
Introduction The prevalence of eye diseases has been increasing worldwide. In China, in addition to conventional medicine, Traditional Chinese Medicine (TCM) plays an important role in maintaining people’s vision health. Although less flexible and targeted than TCM decoction, Chinese Patent Medicine...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e059571.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832584298578837504 |
---|---|
author | Wei Zhou Kai Xu Ziyang Huang Xiaoyu Li Xing Liao Lina Liang Yamin Li Qianqian Zuo |
author_facet | Wei Zhou Kai Xu Ziyang Huang Xiaoyu Li Xing Liao Lina Liang Yamin Li Qianqian Zuo |
author_sort | Wei Zhou |
collection | DOAJ |
description | Introduction The prevalence of eye diseases has been increasing worldwide. In China, in addition to conventional medicine, Traditional Chinese Medicine (TCM) plays an important role in maintaining people’s vision health. Although less flexible and targeted than TCM decoction, Chinese Patent Medicines (CPMs) are stable and well used. In recent years, CPMs have been increasingly used in ophthalmology clinics by TCM practitioners and by Western doctors in general hospitals. However, comprehensive evidence for using CPMs in ophthalmology is lacking.Aim We will apply the methodology of scoping review to systematically search and sort out the available evidence on oral CPMs for the treatment of eye diseases, identify the distribution of evidence in this field and provide a basis for clinical practice and medical decisions.Methods The scoping review will be implemented in the following seven steps: (1) defining the research question; (2) searching National Essential Medicines List (2018 edition), National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2020 edition) and Chinese Pharmacopoeia (2020 edition) for oral CPMs for the treatment of eye diseases; (3) searching Embase, Web of Science, PubMed, Cochrane Library, Chongqing VIP Chinese Scientific Journals Database, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database and Wanfang Database for relevant literature published from inception to December 2021; (4) developing eligibility criteria; (5) screening the studies based on inclusion criteria; (6) extracting relevant data and lastly, (7) collating, summarising and reporting the results.Ethics and dissemination Since the scoping review aims at collecting data from publicly available publications, this study does not require ethical approval. The results will be published in a peer-reviewed journal and presented at scientific conferences. |
format | Article |
id | doaj-art-1b2540e5eda54703a79ee2b10cd34703 |
institution | Kabale University |
issn | 2044-6055 |
language | English |
publishDate | 2022-06-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj-art-1b2540e5eda54703a79ee2b10cd347032025-01-27T14:25:14ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-059571Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocolWei Zhou0Kai Xu1Ziyang Huang2Xiaoyu Li3Xing Liao4Lina Liang5Yamin Li6Qianqian Zuo7Department of Emergency, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China2 Department of Anesthesiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaGuangzhou Institute of Respiratory Disease, Guangzhou, Guangdong, ChinaClinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaIntroduction The prevalence of eye diseases has been increasing worldwide. In China, in addition to conventional medicine, Traditional Chinese Medicine (TCM) plays an important role in maintaining people’s vision health. Although less flexible and targeted than TCM decoction, Chinese Patent Medicines (CPMs) are stable and well used. In recent years, CPMs have been increasingly used in ophthalmology clinics by TCM practitioners and by Western doctors in general hospitals. However, comprehensive evidence for using CPMs in ophthalmology is lacking.Aim We will apply the methodology of scoping review to systematically search and sort out the available evidence on oral CPMs for the treatment of eye diseases, identify the distribution of evidence in this field and provide a basis for clinical practice and medical decisions.Methods The scoping review will be implemented in the following seven steps: (1) defining the research question; (2) searching National Essential Medicines List (2018 edition), National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2020 edition) and Chinese Pharmacopoeia (2020 edition) for oral CPMs for the treatment of eye diseases; (3) searching Embase, Web of Science, PubMed, Cochrane Library, Chongqing VIP Chinese Scientific Journals Database, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database and Wanfang Database for relevant literature published from inception to December 2021; (4) developing eligibility criteria; (5) screening the studies based on inclusion criteria; (6) extracting relevant data and lastly, (7) collating, summarising and reporting the results.Ethics and dissemination Since the scoping review aims at collecting data from publicly available publications, this study does not require ethical approval. The results will be published in a peer-reviewed journal and presented at scientific conferences.https://bmjopen.bmj.com/content/12/6/e059571.full |
spellingShingle | Wei Zhou Kai Xu Ziyang Huang Xiaoyu Li Xing Liao Lina Liang Yamin Li Qianqian Zuo Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol BMJ Open |
title | Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol |
title_full | Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol |
title_fullStr | Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol |
title_full_unstemmed | Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol |
title_short | Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol |
title_sort | clinical application of oral chinese patent medicines in ophthalmology a scoping review protocol |
url | https://bmjopen.bmj.com/content/12/6/e059571.full |
work_keys_str_mv | AT weizhou clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT kaixu clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT ziyanghuang clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT xiaoyuli clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT xingliao clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT linaliang clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT yaminli clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol AT qianqianzuo clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol |